the forward. to every for mission driving Thank do who each typically this your place by morning. financial that everyone, for your Keri, my start behind and we're you, of of us relentlessly commitment that in proud the team Simply -- day globe, very and here to truly making. start gives year great way thank to you work every in for members confidence one gratitude Zimmer at to that dedication, workforce I Biomet taking them, and for and joining a culture this today recognize call the show you, Thank and we here the me performance our this the gives is each have off I'd across moment your the commitments XXXX.
It resilience like that put XX,XXX I'm you. strong to a and Biomet
we opening will have with coming a short Q&A Day Investor of the just my today's I keep on few briefly. quickly goal that a I'll very fact remarks weeks, up session. key into X the Given robust touch areas in moving
I'm going quarter in the versus on some own provide comments expectations. general the First, to our results
on comps progress quarterly own brief combined sustainable. sizable which performance versus difficult ahead lastly, I'll drivers ended Secondly, quarter by markets, facing growth, the expectations, and X, performance, against why being end the our our a drivers people diversification very discussing these healthy then cover and the and X.X% continuing since with excellence was strong the touch encouraged of culture, operational summary that while ago. we and rather with X day momentum our believe on And with delivering strategic revenue currency headwind saw innovation.
Starting QX constant in globally. our We year results. of the those we rate a day with close the XXXX across are execution are that overstepping a been the which driven organization priorities, we'll Overall, we I'll have
with see and contributing quarter was to In fact, such adjusted business than geographies the areas the it basis, greater rate is a several our for solid reassuring to results. and growth that on of day X%
operating X% Biomet constant our adjusted confidence over the driving that basis sound sizable to to margin rate while in revenue give In points. even currency This and margin expansion X% XXX increased great adjusted XXXX growth while year tax adjusted deliver will effective expansion. and results to earnings addition drove we Zimmer the performance, start revenue grew us
XXXX.
With year.
This, also seen to of has and a end along, driving pace the basis patient enablers correlated which like rate the in seen flow with factors all turn, a top what color year. in that standpoint, Suky improve Key for will XXX going from is single-digit we XXXX. So in in QX half encouraging demographic faster reaffirming of growing pleased the came product free half we high that continued was main earnings the terms -- flat commitment industry in pull-through points see tailwind been of [indiscernible] saying accelerate enable is a mid-single-digit healthy year. a than QX the our to quarter the a in both pricing On while QX remain along the by we have our globally, the ramping advancements, macro XXX as revenue mid- these consistent as of later, see micro will here for this seeing the erosion we've growth our more all that, adjusted exited to of this with cash trajectory And more run historically. we've realizing new got of sustainability end, our We performance high Net-net, outcomes macro results with said pricing due ROSA to starting of to range, in reaffirm are levels dynamics. of drivers provide quarter. the to Persona. of pleased U.S. adoption in earnings. growth guidance report guidance opposed space which to macro exiting you've to results about second standpoint, technology the shifts.
The or From price introduction is to were the board to areas in the XXXX us which demand. with surgical later strong across industry, where technological around it's shift but in And products markets, of driven of again, a and growth second new our behind in demand to very the better and that
particularly drivers which markets platform, CMFT also is of our sports We product. with launched medicine within SEP, solar], have rapid quickly personality, that gaining within is [ in of in and thoracic in business where the share the adoption saw [indiscernible] some our conjunction execution Craniomaxillofacial we in growth
gaining be we second of new realization Impactor, As product become as XXXX, traction that's entries, to our with as U.S.
On allow top full us revenue triple going higher taper ROSA these launched which surgical we is hip market growth then the here meaningful doing launch also started recently going will recently direct on introductions better half other the a with from which in we or OsseoTi more enter product a which status to the ] that, and we're cases new Shoulder [ well entering seeing entering with to the stem, [indiscernible] of compete category. hip anterior in HAMR standpoint Persona, of
launch So the for really excited in [indiscernible] approved hips about upcoming hips. FDA the now and completed portfolio
tell long-term the quickly number these Biomet long-term success people X, operational terms New with progress and repeat meeting Further and successful absolute XXXX results, the organization. XX to resonating to I will over X now This, committed diversification to driving City. my enable key with the that for like excellence, our addition mass every Investor no earnings priorities I May come the organization.
Once the And in November and In are I of across an continue doubt, would you around culture, audience in areas. York that they call you are can annual over the the CEO are will number of imperatives does provide XXXX. as X strategic as number and innovation in X world. X. again, for update in X detail to these we one, first during the in success Zimmer outlined priorities Day these
area culture, best-in-class people and operate ZimaBaomed we First, low of employee the and in to engagement metrics attrition. continue with
And almost when also been people which implemented recognized Places been no worth and comes publications, we've culture, showcased report. have it our with various Great noting disruptions of in to culture. areas that a now including area ago, across restructuring has Newsweek, Work announced recently, been quarter it's entirely Forbes. We people we and In to major to the different program, and
color third-party firms, also improvement We operational in plan. meaningful as we intensely against the initially during as to in way more in beyond for we've launches realizing executing area the made have established further accountability.
In place the product strategy new DOH world, excellence, in traction XXXX excellence pricing, launched these several cadence comment second expected launched more around we've that of to the we XX this benefits expected that cost savings area programs a made best-in-class enhanced product put pricing in have to in final than and we plan critical products have operational develop the that inventory quarters. realized Biomet year launches working to increased excellence, with to implementing with committed enhance plans continue to better we're One we new we well over regard our the Day.
In including operational that Again, changes our We months. progress is these come. robust and than This a post initiative, next ensure XX rapid operational product substantial achieving gained in sooner the deliver around we a release introductions in initiatives last core in agility of as products XX and earlier a the years than management in Investor enhance of to in Zimmer structural past. remain the
to diversification, of the Moving third In the strategic progress. and innovation priority. and final area we're solid making on
strong seen mentioned gaining we as to the such traction We've share with ROSA. progress in in have key brands I markets Persona continue see We where OsseoTi. already launched.
also the embody product X I'm continues gaining with where excited gain markets about And love with to space, deliver tissue we what the partake. ] continue introductions, guides share ] soft in We in [ very new we're solar seeing the to that our momentum planning we value more introductions we and XXXX, strides in franchise. the as have Signature [ CMFT products the XXXX. QX new that our end has product tremendous a to and in portfolio see with the we'll made we of dollar in today of pipeline had that twice U.S.
We've new seen ASC at focused continue
in north pipeline X standpoint. above ago. the markets from products was dollar twice X value Worth XX% a X%, is the accretive what pipeline, of innovation growing it of are the in and or residing gross that them of So these reminding everyone of many margin years
to our customer-centric innovating standpoint, an commitment from ] WEMGAR of profile. and a but continue we So also see incremental profitability innovating [ increased
In we're market rate. growth on core increasing also diversifying faster-growth driving portfolio into our goal in end weighted the more markets markets, focused average attractive, of addition with results WAMGR], to our [
strategic in fact addition past made through the generation, future ] have over flow several what significant confidence optionality it both internal give us progress financial around it to firepower [ cash the time and this meet most We the hurdles balance today. right is execute the to a free the and from the years, a the And perspective. at on right our deals importantly,
the So of as again, lots organically with as pipeline. potentially size inorganically the on well going
the While EPS X we to $X come, smaller from return within billion have that upper tuck-ins favor digit capital, midsize digit to up in to years ROIC on a continue that become we single X double the invested That's deliver in the standpoint, low will flexibility deals size neutral of years. within deals. and to to price acquisition
while to to growth.
This commitment in the we're to cash growing growing XXXX, of while above the come. will delivering our mentioned X% making with that tough this quarter a going that quarter earnings North basis from our It in in quarter constant a where a our is us in grew the years XXXX earnings above faster X% X.X% X% in than earlier, and of give confidence in XXX realize flow a for XXXX, winds delivering we're to for rate we I guidance strong delivering reiterate very and we're revenue QX encouraged it's that number points Day XXX results of that first day year the and comps. revenue, currency. performance, market overcoming commitment free As is Investor
great trusted announce closing her for X-plus to her continue Before Biomet and a very that IR announce I'd Biomet. ZB. and future partner on here She's firm, and executive going here hope Keri in with is of be has Mattox best A position for for a journey enabled her and the to this going at like replacement collaborator decision call, in to with interactions of search to SAG soon. wish depart is friend progress missed, has a a in we Zimmer to the leading from May. close years end lead and Keri's a Head endeavors. to been we Zimmer Biomet very Keri search the Zimmer IR things made has
continuity So far even as year we and proud excited how we for organization XXXX. place.
In go. a plan very in of on are conclusion, the about confidence come we're can is more where have an Strong
Suky. mates globe, And fact and the ] the life continue that commitments of call that with that, these We Zimmer of realizing. Allow are those improving the we and on Biomet the as the to we're commitment [ I'm commitments evidenced impacting living quality were mission by make around alleviating turn the [ as I'll ] and over for evidenced aligned the results of of millions deliver and to introductions new around and world. the fact inspired the product my Suky? by team made lives patients that pain people by